Report side effects from approved medications through the Yellow Card Scheme
In this study, with a median follow-up of 25 months, the primary composite end point including cardiovascular death, MI, stroke, and hospitalization for unstable angina occurred in 406 patients (13.4%) in the lixisenatide group and in 399 (13.2%) in the placebo group (HR, 1.02
If your injectable GLP-1 medication appears cloudy, discolored, or contains visible particles, you should not use it
The role of gut microbiota in neurodegenerative diseases: Current insights and therapeutic implications
Related Reading Semaglutide Before and After Zepbound Before And After Glp 1 Before And After Semaglutide Before And After Why Compounded Semaglutide Exists (And Why It's Not the Same Product) Compounded semaglutide emerged because patients couldn't access the FDA-approved version when needed